Effects of the cannabinoid receptor agonist CP-55,940 on incentive salience attribution. - Gheidi A; Cope LM; Fitzpatrick CJ; Froehlich BN; Atkinson R; Groves CK; Barcelo CN; Morrow JD (Psychopharmacology, 2020)